Znn3bq.jpeg
²é¿´: 540  |  »Ø¸´: 2

yukikai

½ð³æ (³õÈëÎÄ̳)

[ÇóÖú] Çë¸÷λ´óÉñ°ïæ·­ÒëһС¶ÎÁÙ´²±¨¸æ ÒÑÓÐ1È˲ÎÓë

AG-120 is being evaluated in an ongoing Phase 1 trial that includes a dose escalation phase and four expansion cohorts, including: Arm 1: 125 IDH1 mutant positive AML patients who relapsed after bone marrow transplantation, are in second or later relapse, refractory to second line induction or reinduction treatment. Arm 2: 25 untreated IDH1 mutant positive AML patients who are not candidates for standard-of-care chemotherapy. Arm 3: 25 patients with other non-AML IDH1 mutant, relapsed or refractory advanced hematologic malignancies. Arm 4: 25 patients with relapsed IDH1 mutant positive AML not eligible for arm 1 or standard of care.
¹òÇó´óÉñ°ï棬һЩרҵµÄ´Ê×é¿´²»¶®Orz
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sqlg888

Ìú³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
yukikai: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2016-01-15 09:39:43
AG-120ÕýÔÚ½øÐÐIÆÚÁÙ´²ÊÔÑéÆÀ¹À£¬°üÀ¨¼ÁÁ¿µÝÔö×éºÍËĸö¼ÁÁ¿À©Õ¹×飬ÕâËĸö°üÀ¨£º
×é1:  125ÀýµÄIDH1Í»±äÑôÐÔAML»¼Õߣ¨¹ÇËèÒÆÖ²ºó¸´·¢¡¢µÚ¶þ´Î¸´·¢»ò¸üºó¸´·¢¡¢ÄÑÖÎÐÔÊôµÚ¶þÐеÄÓÕµ¼»òÔÙÓÕµ¼ÖÎÁÆ£©¡£
×é2:  25ÀýδÖÎÁƵÄIDH1Í»±äÑôÐÔAML»¼Õߣ¨²»Êʺϱê×¼»¯ÁÆ£©¡£
×é3:  25ÀýÆäËûIDH1Í»±ä·ÇAML»¼Õߣ¨¸´·¢ÐÔ»òÄÑÖÎÐÔÍíÆÚѪҺϵͳ¶ñÐÔÖ×Áö£©¡£
×é4:  25Àý¸´·¢IDH1Í»±äÑôÐÔµÄAML»¼Õߣ¨²»·ûºÏ×é1»ò±ê×¼»¯ÁÆ£©¡£


×¢£º
IDH£¨ÒìÄûÃÊËáÍÑÇâø£©£¨Ò»ÀàÊÇÔÚϸ°ûÖÊÖз¢ÏÖµÄIDH1£¬Ò»ÀàÊÇÔÚÏßÁ£ÌåÖз¢ÏÖµÄIDH2£©
AG-120£¨ÒìÄûÃÊËáÍÑÇâøͻ±äµ°°×ÒÖÖÆ¼Á£©ÊÇÒ»ÖÖ¿Ú·þ¼Á£¬ËüÄܹ»Ç¿ÁÒµØÑ¡ÔñÐÔÒÖÖÆIDH1°©»ùÒòÍ»±äλµã¡£
AML¼±ÐÔËèϸ°û°×Ѫ²¡
2Â¥2016-01-14 15:54:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yukikai

½ð³æ (³õÈëÎÄ̳)

ÒýÓûØÌû:
2Â¥: Originally posted by sqlg888 at 2016-01-14 15:54:11
AG-120ÕýÔÚ½øÐÐIÆÚÁÙ´²ÊÔÑéÆÀ¹À£¬°üÀ¨¼ÁÁ¿µÝÔö×éºÍËĸö¼ÁÁ¿À©Õ¹×飬ÕâËĸö°üÀ¨£º
×é1:  125ÀýµÄIDH1Í»±äÑôÐÔAML»¼Õߣ¨¹ÇËèÒÆÖ²ºó¸´·¢¡¢µÚ¶þ´Î¸´·¢»ò¸üºó¸´·¢¡¢ÄÑÖÎÐÔÊôµÚ¶þÐеÄÓÕµ¼»òÔÙÓÕµ¼ÖÎÁÆ£©¡£
×é2:  25Àýδ ...

¸Ðл£¡ÔÙÇë½Ìһϡ°ÄÑÖÎÐÔÊôµÚ¶þÐеÄÓÕµ¼»òÔÙÓÕµ¼ÖÎÁÆ¡±ÊÇʲôÒâË¼ÄØ£¿
3Â¥2016-01-15 09:39:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ yukikai µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 297Çóµ÷¼Á +22 ljy20040718£¡ 2026-04-03 24/1200 2026-04-09 20:48 by yanenwang
[¿¼ÑÐ] »¯¹¤Çóµ÷¼Á£¡ +34 RichLi_ 2026-04-06 34/1700 2026-04-09 20:39 by zhouxiaoyu
[¿¼ÑÐ] Ò»Ö¾Ô¸Öпƴó070300»¯Ñ§£¬314·ÖÇóµ÷¼Á +11 wakeluofu 2026-04-09 11/550 2026-04-09 18:03 by lijunpoly
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖпÆÔº105500רҵ×Ü·Ö315Çóµ÷¼Á +6 lallalh 2026-04-09 7/350 2026-04-09 17:51 by lallalh
[¿¼ÑÐ] 316Çóµ÷¼Á +3 Ïë¶ÁÑо¿Éú( ?¡ß 2026-04-07 3/150 2026-04-09 17:31 by wp06
[¿¼ÑÐ] 085404 293Çóµ÷¼Á +7 ÓÂÔ¶¿â°®314 2026-04-08 7/350 2026-04-09 16:02 by Öí»á·É
[¿¼ÑÐ] »úеר˶273ÇëÇóµ÷¼Á +6 ¸ýÉêÈÉÉê 2026-04-07 6/300 2026-04-08 22:41 by bljnqdcc
[¿¼ÑÐ] 266µ÷¼Á +8 daya sun 2026-04-07 9/450 2026-04-08 20:27 by yutian743
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á +10 ŬÁ¦·Ü¶·112 2026-04-07 10/500 2026-04-08 15:01 by screening
[¿¼ÑÐ] 306Çóµ÷¼Á +3 15287505595 2026-04-03 3/150 2026-04-07 18:08 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 277Çóµ÷¼Á ÊýÒ»104·Ö +9 Æ¿×ÓPZ 2026-04-05 14/700 2026-04-07 17:52 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 285Çóµ÷¼Á +15 ŶßϺôo 2026-04-04 17/850 2026-04-06 23:02 by chenzhimin
[¿¼ÑÐ] £¨µ÷¼Á£©Ò»Ö¾Ô¸±¨¿¼¹þ¶û±õ¹¤Òµ´óѧ0857×ÊÔ´Óë»·¾³×¨Òµ378·Ö¿¼Éú +7 ºÝºÝ¼ÓÓÍ 2026-04-05 8/400 2026-04-06 16:52 by momoð©
[¿¼ÑÐ] 0854Çóµ÷¼Á +4 assdll 2026-04-05 4/200 2026-04-06 12:29 by ÖзÉÔº¿Õ¹ÜѧԺÑ
[¿¼ÑÐ] ²ÄÁÏר˶322·Ö +10 ¹þ¹þ¹þºðºðºð¹þ 2026-04-04 10/500 2026-04-05 21:22 by ѧԱ8dgXkO
[¿¼ÑÐ] 296Çóµ÷¼Á +3 Íô£¡£¿£¡ 2026-04-05 5/250 2026-04-05 17:38 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 283·ÖÇóµ÷¼Á +7 СÄô°®Ñ§Ï° 2026-04-03 7/350 2026-04-04 21:51 by hemengdong
[¿¼ÑÐ] 085400µç×ÓÐÅÏ¢319Çóµ÷¼Á£¨½ÓÊÜ¿çרҵµ÷¼Á£© +5 ÐÇÐDz»Õ£ÑÛà¶ 2026-04-03 6/300 2026-04-04 21:50 by hemengdong
[¿¼ÑÐ] 22408£¬264Çóµ÷¼Á +3 ywh729 2026-04-03 4/200 2026-04-04 11:04 by ywh729
[¿¼ÑÐ] 387Çóµ÷¼Á +4 °®³ÔƬ¶¹ÍÁ 2026-04-03 5/250 2026-04-04 08:10 by °¶ÉϵÄÒ»ÌõÓã
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û